OKYO Pharma Limited (OKYO)
USD 1.07
(0.94%)
USD 1.07
(0.94%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.49 Million | -7.69 Million | -5.46 Million | -1.6 Million | -1.2 Million | -1.98 Million |
| Net Income | -16.8 Million | -13.28 Million | -6.21 Million | -3.37 Million | -1.62 Million | -4.9 Million |
| Depreciation & Amortization | 3866.00 | 3797.00 | 2331.00 | 13.11 Thousand | 5979.00 | 217.82 |
| Deferred income taxes | - | 250.34 Thousand | -9409.00 | 92.94 Thousand | 146.58 Thousand | -1167.34 |
| Stock-based compensation | 1.11 Million | 1.27 Million | 1.71 Million | 544.38 Thousand | 36.34 Thousand | 50.53 Thousand |
| Change in working capital | 2.66 Million | 3.94 Million | -1.02 Million | 1.04 Million | 186.53 Thousand | 176.8 Thousand |
| Other non-cash items | 3.46 Million | 114.99 Thousand | 61.72 Thousand | 83 Thousand | 42.84 Thousand | 2.68 Million |
| Investing Cash Flow | - | -5916.00 | -1669.00 | -18.11 Thousand | -132.66 Thousand | -1322.55 |
| Investments in PPE | -3.00 | -5916.00 | -1669.00 | -6943.00 | - | -1322.55 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -11.15 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -11.17 Thousand | -132.66 Thousand | - |
| Financing Cash Flow | 6.2 Million | 9.32 Million | 2.15 Million | 7.82 Million | 963.31 Thousand | - |
| Debt repayment | - | -2 Million | - | -7.58 Million | -6.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.2 Million | 7.32 Million | 1.42 Million | 230.01 Thousand | 990.63 Thousand | - |
| Other Financing Activities | 6208.51 | 2 Million | 2153.27 | 7.59 Million | -27.32 Thousand | - |
| Accounts receivables | 440.25 Thousand | 167.71 Thousand | 27.37 Thousand | -2809.72 | -543.00 | - |
| Accounts payables | 2.79 Million | 2.96 Million | -297.99 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.22 Million | 982.03 Thousand | -753.25 Thousand | 1.04 Million | 308.88 Thousand | - |
| Cash at beginning of period | 4.04 Million | 2.7 Million | 6.88 Million | 235.48 Thousand | 627.61 Thousand | 2.61 Million |
| Cash at end of period | 826.84 Thousand | 4.04 Million | 2.7 Million | 6.88 Million | 235.48 Thousand | 627.56 Thousand |
| Capital Expenditure | -3.00 | -5916.00 | -1669.00 | -6943.00 | - | -1322.55 |
| Effect of forex changes on cash | 63.49 Thousand | -277.53 Thousand | -872.14 Thousand | 445.21 Thousand | -20.7 Thousand | - |
| Net cash flow / Change in cash | -3.21 Million | 1.34 Million | -4.18 Million | 6.65 Million | -392.13 Thousand | -1.99 Million |
| Free Cash Flow | -9.49 Million | -7.7 Million | -5.46 Million | -1.6 Million | -1.2 Million | -1.99 Million |
| Breakdown | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.8 Million | - | -13.28 Million | -3817.98 | -3891.41 | -5.52 Million |
| Depreciation & Amortization | 3866.00 | - | 3797.00 | 1.05 | 1.07 | 1661.94 |
| Deferred income taxes | - | - | 250.34 Thousand | - | - | 131.24 Thousand |
| Stock-based compensation | 1.11 Million | - | 1.27 Million | 348.09 | 357.27 | 318.16 |
| Change in working capital | 2.66 Million | - | 3.94 Million | -32.31 | -29.28 | 1.18 Million |
| Other non-cash items | 3.46 Million | - | 114.99 Thousand | 1449.59 | 1463.98 | 682.01 Thousand |
| Investing Cash Flow | - | - | -5916.00 | -1.46 | -1.50 | -2942.97 |
| Investments in PPE | - | - | -5916.00 | -1.46 | -1.50 | -2942.97 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 6.2 Million | - | 9.32 Million | 3743.64 | 3767.56 | 1.8 Million |
| Debt repayment | - | - | -2 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.2 Million | - | 7.32 Million | - | - | 2.42 Million |
| Other Financing Activities | - | - | 2 Million | 3743.64 | 3767.56 | -627.04 Thousand |
| Accounts receivables | 440.25 Thousand | - | 167.71 Thousand | -68.76 | -66.97 | 134.84 Thousand |
| Accounts payables | 2.79 Million | - | 2.96 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.22 Million | - | 982.03 Thousand | 36.46 | 37.69 | 1.05 Million |
| Cash at beginning of period | 4.04 Million | - | 2.7 Million | 707.31 Thousand | -264.17 | 2.7 Million |
| Cash at end of period | 826.84 Thousand | - | 4.04 Million | 707.31 Thousand | 1264.77 | 707.31 Thousand |
| Capital Expenditure | - | - | -5916.00 | -1.46 | -1.50 | -2942.97 |
| Effect of forex changes on cash | 63.49 Thousand | - | -277.53 Thousand | -138.77 | -138.77 | -274.18 Thousand |
| Net cash flow / Change in cash | -3.21 Million | - | 1.34 Million | - | 1528.94 | -1.99 Million |
| Free Cash Flow | -9.49 Million | - | -7.7 Million | -2053.01 | -2099.86 | -3.52 Million |
FAS
OCX
0JTQ
NGIL
PANAMAPET
3485